North American Myocardial Infarction Market Size, Share & Trends Analysis Report and Forecast, 2022-2028
North American myocardial infarction market is estimated to grow significantly at a CAGR of around 6.6% during the forecast period. North America contributes the highest share in the global myocardial infarction treatment market owing to the highest adoption devices and surgeries that are required for the treatment of MI. In the US alone, around 0.6 million people lose their life due to heart diseases, according to the WHO, the incidence & prevalence rate of heart attack are the highest in North America which is responsible for 0.7 million fatalities each year. According to the Heart & Stroke Foundation, in Canada alone, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease. Moreover, the growing CVD, CHD, stroke and other heart diseases, highest healthcare spending, technological advancement and adoption of hybrid operating rooms and minimally invasive surgeries are the key drivers of the MI treatment market in the region.
Get Free Sample link @ https://www.omrglobal.com/request-sample/north-american-myocardial-infarction-market
The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.
A full report of North American Myocardial Infarction Market available @ https://www.omrglobal.com/industry-reports/north-american-myocardial-infarction-market
· Market Coverage
· Market number available for – 2022-2028
· Base year- 2021
· Forecast period- 2022-2028
· Segment Covered- By Source, By Product Type, By Applications
· Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
North American Myocardial Infarction Market by Type
o Non-ST-elevation myocardial infarction (NSTEMI)
o ST-elevation myocardial infarction (STEMI)
o Silent Heart Attacks
North American Myocardial Infarction Market by Device
o Left Ventricular Assist Device (LVAD)
o Pacemaker
o Catheters
o Implantable Cardioverter-Defibrillator (ICD)
o Others (Stent Graft)
North American Myocardial Infarction Market by Diagnosis
o Electrocardiography (ECG)
o Chest X-Ray
o Computed Tomography (CT Scan)
o Echocardiography
o Others (Blood Test)
North American Myocardial Infarction Market by Treatment
o Medication
o Analgesics
o Thrombolytic
o Antiplatelet Agents
o Glycoprotein IIb/IIIa Inhibitors
o Others (Beta-Adrenergic Blockers)
o Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant
North American Myocardial Infarction Market by End-User
o Hospital & Clinics
o Ambulatory Surgical Centers
o Research Institutes
Regional Analysis
o United States
o Canada
Company Profiles
o Abbott Laboratories Inc.
o AstraZeneca PLC
